NMR solution structure of a cyanovirin homolog from wheat head blight fungus

Proteins: Structure, Function and Bioinformatics

Volumn 79, Issue 5, 2011, Pages 1538-1549

  Matei, Elena ^a   Louis, John M ^b   Jee, Jungoo ^a,c   Gronenborn, Angela M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c TOKYO METROPOLITAN UNIVERSITY   (Japan)

Author keywords

Antiviral protein; CVNH; HIV; Lectin; NMR solution structure

Indexed keywords

CYANOVIRIN N;

AMINO ACID SEQUENCE; ARTICLE; GIBBERELLA; GIBBERELLA ZEAE; NEUROSPORA CRASSA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN STRUCTURE; TUBER (GENUS); TUBER BORCHII;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANTI-HIV AGENTS; BACTERIAL PROTEINS; CARRIER PROTEINS; CELL LINE; FUNGAL PROTEINS; GIBBERELLA; HIV-1; HUMANS; LECTINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID;

CERATOPTERIS RICHARDII; FUNGI; GIBBERELLA ZEAE; NEUROSPORA CRASSA; TRITICUM AESTIVUM; TUBER BORCHII;

EID: 79954623874     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.22981     Document Type: Article

References (42)

1. Sharon N, Lis H. Lectins: cell-agglutinating and sugar-specific proteins. Science 1972; 177: 949-959.
2. Sharon N. Bacterial lectins, cell-cell recognition and infectious disease. FEBS Lett 1987; 217: 145-157.
3. Swamy BM, Bhat AG, Hegde GV, Naik RS, Kulkarni S, Inamdar SR. Immunolocalization and functional role of Sclerotium rolfsii lectin in development of fungus by interaction with its endogenous receptor. Glycobiology 2004; 14: 951-957.
4. Percudani R, Montanini B, Ottonello S. The anti-HIV cyanovirin-N domain is evolutionarily conserved and occurs as a protein module in eukaryotes. Proteins 2005; 60: 670-678.
5. Bewley CA, Gustafson KR, Boyd MR, Covell DG, Bax A, Clore GM, Gronenborn AM. Solution structure of cyanovirin-N, a potent HIV-inactivating protein. Nat Struct Biol 1998; 5: 571-578.
6. Koharudin LM, Viscomi AR, Jee JG, Ottonello S, Gronenborn AM. The evolutionarily conserved family of cyanovirin-N homologs: structures and carbohydrate specificity. Structure 2008; 16: 570-584.
7. Boyd MR, Gustafson KR, McMahon JB, Shoemaker RH, O'Keefe BR, Mori T, Gulakowski RJ, Wu L, Rivera MI, Laurencot CM, Currens MJ, Cardellina JH, II, Buckheit RW, Jr, Nara PL, Pannell LK, Sowder RC, II, Henderson LE. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob Agents Chemother 1997; 41: 1521-1530.
8. O'Keefe BR, Smee DF, Turpin JA, Saucedo CJ, Gustafson KR, Mori T, Blakeslee D, Buckheit R, Boyd MR. Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin. Antimicrob Agents Chemother 2003; 47: 2518-2525.
9. Barrientos LG, Matei E, Lasala F, Delgado R, Gronenborn AM. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition. Protein Eng Des Sel 2006; 19: 525-535.
10. Fromme R, Katiliene Z, Giomarelli B, Bogani F, Mc Mahon J, Mori T, Fromme P, Ghirlanda G. A monovalent mutant of cyanovirin-N provides insight into the role of multiple interactions with gp120 for antiviral activity. Biochemistry 2007; 46: 9199-9207.
11. Matei E, Furey W, Gronenborn AM. Solution and crystal structures of a sugar binding site mutant of cyanovirin-N: no evidence of domain swapping. Structure 2008; 16: 1183-1194.
12. Matei E, Zheng A, Furey W, Rose J, Aiken C, Gronenborn AM. Anti-HIV activity of defective cyanovirin-N mutants is restored by dimerization. J Biol Chem; 285: 13057-13065.
13. Bai GH, Chen LF, Shaner GE. Breeding for resistance to Fusarium head blight of wheat in China. In: Leonard KJ, Bushnell WR, editors. Fusarium head blight of wheat and barley. St Paul, MN: APS Press; 2003. pp 296-317.
14. Bennett JW, Klich M. Mycotoxins Clin Microbiol Rev 2003; 16: 497-516.
15. Gale LR, Bryant JD, Calvo S, Giese H, Katan T, O'Donnell K, Suga H, Taga M, Usgaard TR, Ward TJ, Kistler HC. Chromosome complement of the fungal plant pathogen Fusarium graminearum based on genetic and physical mapping and cytological observations. Genetics 2005; 171: 985-1001.
16. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 1995; 6: 277-293.
17. Johnson BA. Using NMRView to visualize and analyze the NMR spectra of macromolecules. Methods Mol Biol 2004; 278: 313-352.
18. Bax A, Grzesiek S. Methodological advances in protein NMR. Acc Chem Res 1993; 26: 131-138.
19. Fesik SW, Zuiderweg ER. Heteronuclear three-dimensional NMR spectroscopy of isotopically labelled biological macromolecules. Q Rev Biophys 1990; 23: 97-131.
20. Grzesiek S, Vuister GW, Bax A. A simple and sensitive experiment for measurement of JCC couplings between backbone carbonyl and methyl carbons in isotopically enriched proteins. J Biomol NMR 1993; 3: 487-493.
21. Logan TM, Olejniczak ET, Xu RX, Fesik SW. A general method for assigning NMR spectra of denatured proteins using 3D HC(CO)NH-TOCSY triple resonance experiments. J Biomol NMR 1993; 3: 225-231.
22. Sattler M, Maurer M, Schleucher J, Griesinger C. A Simultaneous 15N, 1H-HSQC and 13C, 1H-HSQC with sensitivity enhancement and a heteronuclear gradient-echo. J Biomol NMR 1995; 5: 97-102.
23. Herrmann T, Guntert P, Wuthrich K. Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J Mol Biol 2002; 319: 209-227.
24. Guntert P, Mumenthaler C, Wuthrich K. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J Mol Biol 1997; 273: 283-298.
25. Cornilescu G, Delaglio F, Bax A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR 1999; 13: 289-302.
26. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 1998; 54 (Part 5): 905-921.
27. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK-a program to check the stereochemical quality of protein structures. J Appl Crystallog 1993; 26: 83-291.
28. Bhattacharya A, Wunderlich Z, Monleon D, Tejero R, Montelione GT. Assessing model accuracy using the homology modeling automatically software. Proteins 2007; 66: 778-795.
29. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997; 18: 2714-2723.
30. Wüthrich K. NMR of proteins and nucleic acids. New York: Wiley; 1986.
31. Yang RAiken C. A mutation in alpha helix 3 of CA renders human immunodeficiency virus type 1 cyclosporin A resistant and dependent: rescue by a second-site substitution in a distal region of CA. J Virol 2007; 81: 3749-3756.
32. Bewley CA, Otero-Quintero S. The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120. J Am Chem Soc 2001; 123: 3892-3902.
33. Shenoy SR, Barrientos LG, Ratner DM, O'Keefe BR, Seeberger PH, Gronenborn AM, Boyd MR. Multisite and multivalent binding between cyanovirin-N and branched oligomannosides: calorimetric and NMR characterization. Chem Biol 2002; 9: 1109-1118.
34. Ramachandran GN, Sasisekharan V. Conformation of polypeptides and proteins. Adv Protein Chem 1968; 23: 283-438.
35. Thoronton JM. Disulphide bridges in globular proteins. J Mol Biol 1981; 151: 261-287.
36. Gustafson KR, Sowder RC, II, Henderson LE, Cardellina JH, II, McMahon JB, Rajamani U, Pannell LK, Boyd MR. Isolation, primary sequence determination, and disulfide bond structure of cyanovirin-N, an anti-HIV (human immunodeficiency virus) protein from the cyanobacterium Nostoc ellipsosporum. Biochem Biophys Res Commun 1997; 238: 223-228.
37. Yang F, Bewley CA, Louis JM, Gustafson KR, Boyd MR, Gronenborn AM, Clore GM, Wlodawer A. Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping. J Mol Biol 1999; 288: 403-412.
38. Barrientos LG, Louis JM, Botos I, Mori T, Han Z, O'Keefe BR, Boyd MR, Wlodawer A, Gronenborn AM. The domain-swapped dimer of cyanovirin-N is in a metastable folded state: reconciliation of X-ray and NMR structures. Structure 2002; 10: 673-686.
39. Botos I, Mori T, Cartner LK, Boyd MR, Wlodawer A. Domain-swapped structure of a mutant of cyanovirin-N. Biochem Biophys Res Commun 2002; 294: 184-190.
40. Fromme R, Katiliene Z, Fromme P, Ghirlanda G. Conformational gating of dimannose binding to the antiviral protein cyanovirin revealed from the crystal structure at 1.35 A resolution. Protein Sci 2008; 17: 939-944.
41. Sandstrom C, Hakkarainen B, Matei E, Glinchert A, Lahmann M, Oscarson S, Kenne L, Gronenborn AM. Atomic mapping of the sugar interactions in one-site and two-site mutants of cyanovirin-N by NMR spectroscopy. Biochemistry 2008; 47: 3625-3635.
42. Botos I, O'Keefe BR, Shenoy SR, Cartner LK, Ratner DM, Seeberger PH, Boyd MR, Wlodawer A. Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides. J Biol Chem 2002; 277: 34336-34342.